In vivo studies of GABAergic effects in experimental hepatic encephalopathy
β Scribed by David Rzepczynski; Leslie Zieve; Sandra Lindblad; Darlene Lafontaine
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 539 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The GABAergic agonist, muscimol, and antagonists, picrotoxin and bicuculline, have been studied in rats with chronic portacaval shunts and in rats developing hepatic encephalopathy after massive ischemic necrosis due to hepatic artery ligation within 48 hr of a portacaval shunt. After the chronic portacaval shunt and to a lesser extent in normal rats intraventricular muscimol resulted in chewing and eating behavior, ataxia and loss of balance that lasted 2 to 3 hr. Lethargy, stupor and coma did not occur. Intraventricular saline had no effect. Bicuculline i.p. lessened the effects of the muscimol. In rats developing hepatic encephalopathy, intraventricular muscimol shortened the time to precoma and coma by approximately 40%. Bicuculline i.p. counteracted this effect of muscimol significantly. However, neither bicuculline nor picrotoxin given alone altered the times to precoma (Stage 111), coma (Stage IV) or death. While hepatic encephalopathy in this experimental model is susceptible to GABAergic effects, its natural progression does not appear to be due to GABA.
A GABAergic effect has been suggested as the basis for hepatic coma because in uitro studies in rabbits and rats have found an increased density of GABA receptors on brain synaptosomes after severe liver damage with galactosamine (1, 2). Increased amounts of GABA were thought to pass through an abnormally permeable bloodbrain barrier into the brain where it was bound to receptors for GABA on postsynaptic neural membranes. This resulted in increased chloride ion conductance across the membrane, hyperpolarization and generation of inhibitory postsynaptic potentials (1). Since GABA is a prominent inhibitory neurotransmitter normally, it was assumed that increased amounts of GABA on synaptosomes during hepatic failure resulted in hepatic encephalopathy (HE). Jones and coworkers (1) attributed the encephalopathy entirely t o GABA, finding no role for ammonia and other toxins of hepatic failure. Baraldi and Zeneroli (3) suggested that the depressant effect of GABA was on neurons already damaged by the toxinsammonia, mercaptans and fatty acids-that accumulate with hepatic failure and were thus sensitized to the effects of GABA.
π SIMILAR VOLUMES
The brain energy metabolism of rats affected by chronic hepatic encephalopathy due to portacaval shunting was monitored by in vivo 31 P-nuclear magnetic resonance spectroscopy before and after ammonium acetate administration. With respect to healthy unoperated and to sham operated controls, portacav
BACKGROUND AND PURPOSE: MR imaging and MR spectroscopy are increasingly being used to determine response to pharmacologic therapy. Hepatic encephalopathy (HE) is characterized by abnormal cerebral metabolites, yet the response to lactulose and other anti-HE measures is still primarily determined by
## Abstract ## Purpose: To evaluate regional cerebral metabolic and structural changes in patients with minimal hepatic encephalopathy (MHE) using twoβdimensional (2D) MR spectroscopy (MRS) and Tβweighted MRI, to correlate the observed MR changes with neuropsychological (NP) test scores, and to co
During the development of acute hepatic encephalopathy, induced by acute liver ischemia, changes in brain 31P NMR spectra and EEG spectra were studied over 8:45 h in eight rats. At the end of this period the brain amino acid concentrations were determined. The results were compared with the same mea